• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Search Results

 Cefazolin Injection

 Status: Currently in Shortage

 » Date first posted: 04/01/2014
 » Therapeutic Categories: Anti-Infective; Pediatric

Apotex Corp. (Revised 01/27/2016)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1gm; (25 Vials) (NDC 60505-0749-5) On backorder. Backorder due to the large number of customer orders that have been exceeding forecasts. Demand increase for the drug
1gm; (25 Vials)(NDC 60505-6093-5) On backorder. Backorder due to the large number of customer orders that have been exceeding forecasts. Demand increase for the drug
10 gm; (10 Vials) (NDC 60505-0769-0) Backorder status is expected to resolve by February 2016 Backorder due to the large number of customer orders that have been exceeding forecasts. Demand increase for the drug
10 gm; (10 Vials) (NDC 60505-6094-0) On backorder. Backorder due to the large number of customer orders that have been exceeding forecasts. Demand increase for the drug

B. Braun Medical Inc. (Reverified 06/18/2015)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 g Cefazolin (NDC 0264-3105-11) Product available for contracted customers based on historical use. Demand increase for the drug
1 g Cefazolin NDC (NDC 0264-3103-11) Product available for contracted customers based on historical use. Demand increase for the drug

Baxter Healthcare (Reverified 02/09/2016)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
USP 1 g/50 mL (NDC 0338-3503-41) Available Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 02/10/2016)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg / single dose vial (NDC 63323-0236-10) Available Check wholesalers for inventory. Demand increase for the drug
1 g / single dose vial (NDC 63323-0237-10) Available Check wholesalers for inventory. Demand increase for the drug
10 g / PBP (NDC 63323-0238-61) Available Check wholesalers for inventory. Demand increase for the drug
20 g / PBP (NDC 63323-449-61) Available Check wholesalers for inventory. Demand increase for the drug

Hospira, Inc. (Reverified 02/05/2016)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g; vial (NDC 0409-0805-01) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available Other
10 g; Pharmacy Bulk Package (NDC 0409-0806-01) Available Please check with your wholesaler for available inventory. Other
1 g; Add-Vantage vial (NDC 0409-2585-01) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available Other

Sagent Pharmaceuticals (Reverified 02/10/2016)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500mg 10mL vial, (NDC 25021-100-10) Product is on allocation Demand increase for the drug
1g 10mL vial, (NDC 25021-101-10) Product is on allocation Demand increase for the drug

Sandoz (Reverified 02/12/2016)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg (NDC 00781-9338-95) Available Other
500 mg (NDC 00781-3450-95) Available Other
1g (NDC 00781-3451-96) Available Other
10g (NDC 00781-3452-95) Available Other

West-Ward Pharmaceuticals (Revised 12/17/2015)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g/10 mL vial (NDC 0143-9924-90) Slight backorder situation Product is expected to be available during the last few weeks of December 2015. This will cover the backorder situation. Additional units will be available in the January – February 2016 timeframe. Product will be made available as it is released. Demand increase for the drug
10 mg/100 mL vial (NDC 0143-9983-03) Inventory available Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
500 mg/10mL vial (NDC 0143-9923-90) Inventory available Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug

WG Critical Care (Reverified 01/28/2016)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500mg vial (NDC 44567-0706-25) Available Please check wholesalers and distributors for availability. Demand increase for the drug
1g vial (NDC 44567-0707-25) Available Please check wholesalers and distributors for availability. Demand increase for the drug
10g vial (NDC 44567-0708-10) Available Please check wholesalers and distributors for availability. Demand increase for the drug
-
-